Cvs Health (CVS) Cash from Investing Activities (2009 - 2026)

Cvs Health (CVS) has 18 years of Cash from Investing Activities data on file, last reported at -$874.0 million in Q1 2026.

• Quarterly Cash from Investing Activities fell 14.7% year-over-year to -$874.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.0 billion (up 4.74% YoY) and the FY2025 annual result came in at -$5.9 billion, up 22.88% from the prior year.
• Cash from Investing Activities climbed to -$874.0 million in Q1 2026, from -$2.0 billion in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$119.0 million in Q4 2022 to a low of -$10.4 billion in Q2 2023.
• A 5-year average of -$2.4 billion and a median of -$1.6 billion in 2024 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities soared 91.74% — and 2023, when it slumped 943.7%.
• Tracing CVS's Cash from Investing Activities over 5 years: stood at -$119.0 million in 2022, then tumbled by 943.7% to -$1.2 billion in 2023, then surged by 55.96% to -$547.0 million in 2024, then slumped by 265.27% to -$2.0 billion in 2025, then jumped by 56.26% to -$874.0 million in 2026.
• The last three Cash from Investing Activities figures came in at -$874.0 million (Q1 2026), -$2.0 billion (Q4 2025), and -$2.1 billion (Q3 2025), per Business Quant data.